{"transactions":[{"id":1873456,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CAO"}}],"security":"Restricted Stock Unit","published_at":"2023-05-31T20:17:37.000Z","date":"2022-08-10","kind":"exercise","planned":false,"acquired":false,"shares":10457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":115037,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10457},"source":{"system":"sec-edgar","filing":"0001209191-23-033108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123033108/doc4.xml","form_type":"4"}},{"id":1873455,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CAO"}}],"security":"Restricted Stock Unit","published_at":"2023-05-31T20:17:37.000Z","date":"2022-07-01","kind":"exercise","planned":false,"acquired":false,"shares":5139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":77097,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5139},"source":{"system":"sec-edgar","filing":"0001209191-23-033108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123033108/doc4.xml","form_type":"4"}},{"id":1873454,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CAO"}}],"security":"Class A Common Stock","published_at":"2023-05-31T20:17:37.000Z","date":"2022-08-12","kind":"sale","planned":false,"acquired":false,"shares":3166,"price":2.17,"value":6870.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":43040,"source":{"system":"sec-edgar","filing":"0001209191-23-033108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123033108/doc4.xml","form_type":"4"}},{"id":1873453,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CAO"}}],"security":"Class A Common Stock","published_at":"2023-05-31T20:17:37.000Z","date":"2022-08-10","kind":"exercise","planned":false,"acquired":true,"shares":10457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":46206,"source":{"system":"sec-edgar","filing":"0001209191-23-033108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123033108/doc4.xml","form_type":"4"}},{"id":1873452,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CAO"}}],"security":"Class A Common Stock","published_at":"2023-05-31T20:17:37.000Z","date":"2022-07-05","kind":"sale","planned":false,"acquired":false,"shares":1497,"price":1.3187,"value":1974.0939,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.215 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":35749,"source":{"system":"sec-edgar","filing":"0001209191-23-033108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123033108/doc4.xml","form_type":"4"}},{"id":1873451,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CAO"}}],"security":"Class A Common Stock","published_at":"2023-05-31T20:17:37.000Z","date":"2022-07-01","kind":"exercise","planned":false,"acquired":true,"shares":5139,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":37246,"source":{"system":"sec-edgar","filing":"0001209191-23-033108","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919123033108/doc4.xml","form_type":"4"}},{"id":2273625,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-05-13T00:27:11.000Z","date":"2022-05-10","kind":"exercise","acquired":false,"shares":10457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":125494,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10457},"source":{"system":"sec-edgar","filing":"0001209191-22-028698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122028698/doc4.xml","form_type":"4"}},{"id":2273624,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-13T00:27:11.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":3128,"price":1.7504,"value":5475.2512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":32107,"source":{"system":"sec-edgar","filing":"0001209191-22-028698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122028698/doc4.xml","form_type":"4"}},{"id":2273623,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-13T00:27:11.000Z","date":"2022-05-10","kind":"exercise","acquired":true,"shares":10457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":35235,"source":{"system":"sec-edgar","filing":"0001209191-22-028698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122028698/doc4.xml","form_type":"4"}},{"id":2302695,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-04-06T21:18:46.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":82236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":82236,"derivative":{"underlying":"Class A Common Stock","underlying_shares":82236},"source":{"system":"sec-edgar","filing":"0001209191-22-023521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122023521/doc4.xml","form_type":"4"}},{"id":2302694,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-06T21:18:46.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":142772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":142772,"derivative":{"exercise_price":3.05,"expiration_date":"2032-04-03","underlying":"Class A Common Stock","underlying_shares":142772},"source":{"system":"sec-edgar","filing":"0001209191-22-023521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122023521/doc4.xml","form_type":"4"}},{"id":2398454,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T01:44:32.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":10457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/16th of the total shares vested beginning on October 25, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":135951,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10457},"source":{"system":"sec-edgar","filing":"0001209191-22-009575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122009575/doc4.xml","form_type":"4"}},{"id":2398453,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-15T01:44:32.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":3647,"price":3.64,"value":13275.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.64 to $3.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":24777,"source":{"system":"sec-edgar","filing":"0001209191-22-009575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122009575/doc4.xml","form_type":"4"}},{"id":2398452,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-15T01:44:32.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":10457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":28424,"source":{"system":"sec-edgar","filing":"0001209191-22-009575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919122009575/doc4.xml","form_type":"4"}},{"id":2486301,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-04T00:01:05.000Z","date":"2021-12-01","kind":"tax_withholding","acquired":false,"shares":82,"price":5.52,"value":452.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover certain tax obligation in connection with the stock bonus granted to the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":17967,"source":{"system":"sec-edgar","filing":"0001209191-21-067990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121067990/doc4.xml","form_type":"4"}},{"id":2486300,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-04T00:01:05.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":249,"price":6.05,"value":1506.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The indicated shares were issued to Reporting Person as a stock bonus in connection with the elimination of Issuer's sabbatical leave program, in which all employees of Issuer hired on or before June 30, 2021 were provided an opportunity to receive a stock bonus in lieu of their continued eligibility to take sabbatical leave.  The stock bonus was fully vested as of the date of issuance."}],"balance_after":18049,"source":{"system":"sec-edgar","filing":"0001209191-21-067990","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121067990/doc4.xml","form_type":"4"}},{"id":2513006,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-11-15T22:35:59.000Z","date":"2021-11-10","kind":"exercise","acquired":false,"shares":10457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/16th of the total shares vested on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/16th of the total shares vested on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":146408,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10457},"source":{"system":"sec-edgar","filing":"0001209191-21-064519","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121064519/doc4.xml","form_type":"4"}},{"id":2513005,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-15T22:35:59.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":3114,"price":7.87,"value":24507.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":17800,"source":{"system":"sec-edgar","filing":"0001209191-21-064519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121064519/doc4.xml","form_type":"4"}},{"id":2513004,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-15T22:35:59.000Z","date":"2021-11-10","kind":"exercise","acquired":true,"shares":10457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":20914,"source":{"system":"sec-edgar","filing":"0001209191-21-064519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121064519/doc4.xml","form_type":"4"}},{"id":2529196,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-11-03T00:29:09.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":34776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Form 4 is being amended to correct the vesting schedule as to 25% of the total shares vest on October 1, 2023, and thereafter as to 75% of the total shares underlying the award in quarterly installments until fully vested on October 1, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This Form 4 is being amended to correct the vesting schedule as to 25% of the total shares vest on October 1, 2023, and thereafter as to 75% of the total shares underlying the award in quarterly installments until fully vested on October 1, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":34776,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34776},"source":{"system":"sec-edgar","filing":"0001209191-21-062559","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121062559/doc4a.xml","form_type":"4/A","original_submission_date":"2020-10-06"}},{"id":2529195,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-11-03T00:27:49.000Z","date":"2021-10-25","kind":"exercise","acquired":false,"shares":10457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/16th of the total shares vested on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/16th of the total shares vested on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":156865,"derivative":{"underlying":"Class A Common Stock","underlying_shares":10457},"source":{"system":"sec-edgar","filing":"0001209191-21-062556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121062556/doc4.xml","form_type":"4"}},{"id":2529194,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T00:27:49.000Z","date":"2021-10-25","kind":"exercise","acquired":true,"shares":10457,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":10457,"source":{"system":"sec-edgar","filing":"0001209191-21-062556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121062556/doc4.xml","form_type":"4"}},{"id":2547296,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-10-07T01:11:35.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":34776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total shares vest on October 1, 2022, and thereafter vests as to 75% of the total shares underlying the award in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the total shares vest on October 1, 2022, and thereafter vests as to 75% of the total shares underlying the award in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":34776,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34776},"source":{"system":"sec-edgar","filing":"0001209191-21-059876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121059876/doc4.xml","form_type":"4"}},{"id":2549354,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-10-06T01:47:16.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":167322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/16th of the total shares vest on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1/16th of the total shares vest on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":167322,"derivative":{"underlying":"Class A Common Stock","underlying_shares":167322},"source":{"system":"sec-edgar","filing":"0001209191-21-059760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121059760/doc4.xml","form_type":"4"}},{"id":2549353,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":112964,"kind":"person","name":"Assad Shawn","position":1,"cik":"0001873887","reported_name":"Assad Shawn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-06T01:47:16.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":96830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/16th of the total shares vest on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":96830,"derivative":{"exercise_price":7.62,"expiration_date":"2031-09-30","underlying":"Class A Common Stock","underlying_shares":96830},"source":{"system":"sec-edgar","filing":"0001209191-21-059760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120919121059760/doc4.xml","form_type":"4"}}]}